Skip to main content
Fig. 1 | Clinical Epigenetics

Fig. 1

From: The role of myocardial energy metabolism perturbations in diabetic cardiomyopathy: from the perspective of novel protein post-translational modifications

Fig. 1

The discovery process and molecular structure of PTMs related to metabolic disturbance in DbCM. With the development of acyl antibodies and continuous improvement in the accuracy of MS detection, many PTMs related to metabolic disturbance of DbCM cardiomyocytes have been discovered in recent years, and the red part of their molecular structure is the corresponding acyl modification group

Back to article page